![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CardioFocus Launches Trial for HeartLight Device
CardioFocus Launches Trial for HeartLight Device
![Purple_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Purple_Approved_Stamp.gif?t=1576639773&width=430)
March 1, 2018
CardioFocus is launching a clinical trial for its HeartLight direct-visualization ablation device for treating atrial fibrillation.
The device enables electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility.
The first HeartLight version won pre-market approval from the FDA in April 2016.
Upcoming Events
-
21Oct